- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 27.05. | Shuttle Pharmaceuticals Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 14.05. | Shuttle Pharmaceuticals Holdings Inc.: Shuttle Pharmaceuticals and United Dogecoin Announce Purchase Order for up to 3,000 ElphaPex Dogecoin and Litecoin Mining Rigs | 480 | Newsfile | Gaithersburg, Maryland--(Newsfile Corp. - May 14, 2026) - Shuttle Pharmaceutical Holdings, Inc. (NASDAQ: SHPH) ("Shuttle" or the "Company") today announced the closing (the "Closing") of its previously... ► Artikel lesen | |
| 14.05. | Shuttle Pharma completes merger with United Dogecoin | 2 | Investing.com | ||
| 01.05. | Shuttle Pharmaceuticals Holdings Inc.: United Dogecoin Goes Public in Landmark Merger, Powering a Scaled, Next Generation DOGE Mining Operation | 685 | Newsfile | Gaithersburg, Maryland--(Newsfile Corp. - May 1, 2026) - Shuttle Pharmaceutical Holdings, Inc. (NASDAQ: SHPH) ("Shuttle") has entered into a definitive merger agreement to acquire United Dogecoin... ► Artikel lesen | |
| 01.05. | Shuttle Pharmaceuticals Holdings, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 30.04. | Shuttle Pharmaceuticals Holdings Inc.: Shuttle Merges with United Dogecoin to Become the World's Largest Public Dogecoin Miner | 726 | Newsfile | Gaithersburg, Maryland--(Newsfile Corp. - April 30, 2026) - Shuttle Pharmaceutical Holdings, Inc. (NASDAQ: SHPH) ("Shuttle") has entered into a definitive merger agreement to acquire United Dogecoin... ► Artikel lesen | |
| 31.03. | Shuttle Pharmaceuticals Holdings, Inc. - 10-K, Annual Report | - | SEC Filings | ||
| SHUTTLE PHARMACEUTICALS Aktie jetzt für 0€ handeln | |||||
| 26.03. | Shuttle Pharma expands AI drug discovery platform capabilities | 4 | Investing.com | ||
| 26.03. | Shuttle Pharmaceuticals Holdings Inc.: Shuttle Pharmaceuticals Launches Autonomous Self Reasoning AI Agent for Scientific Workflows | 509 | Newsfile | Gaithersburg, Maryland--(Newsfile Corp. - March 26, 2026) - Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) ("Shuttle Pharma" or the "Company"), today announced a major advancement to its... ► Artikel lesen | |
| 12.03. | E.F. Hutton places $3.5M offering for Shuttle Pharmaceuticals | 1 | Investing.com | ||
| 12.03. | E.F. Hutton begleitet Kapitalerhöhung von Shuttle Pharmaceuticals über 3,5 Mio. US-Dollar | 1 | Investing.com Deutsch | ||
| 06.03. | Shuttle Pharmaceuticals announces $3.5 million public offering | 1 | Seeking Alpha | ||
| 06.03. | Shuttle Pharmaceuticals sichert sich 3,5 Mio. US-Dollar durch öffentliche Platzierung | 1 | Investing.com Deutsch | ||
| 06.03. | Shuttle Pharmaceuticals raises $3.5M in public offering | 2 | Investing.com | ||
| 06.03. | Shuttle Pharmaceuticals Holdings Inc.: Shuttle Pharmaceuticals Announces $3.5 Million Public Offering | 327 | Newsfile | Gaithersburg, Maryland--(Newsfile Corp. - March 6, 2026) - Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) ("Shuttle Pharma" or the "Company"), the owner of Molecule.ai, an artificial intelligence... ► Artikel lesen | |
| 17.02. | Shuttle Pharmaceuticals Holdings, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 11.02. | Shuttle Pharmaceuticals Holdings, Inc. - S-1, General form for registration of securities | - | SEC Filings | ||
| 02.02. | Shuttle Pharmaceuticals verlängert Beratervertrag mit Interims-CEO | - | Investing.com Deutsch | ||
| 02.02. | Shuttle Pharmaceuticals Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 13.01. | Shuttle Pharmaceuticals Holdings Inc.: Utah Approves AI Prescriptions Drugs. How AI Is Saving Time, Cutting Costs - and Why Molecule.ai's Drug Discovery Platform Matters More Than Ever | 488 | Newsfile | Gaithersburg, Maryland--(Newsfile Corp. - January 13, 2026) - Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) ("Shuttle Pharma" or the "Company"), applauds the state of Utah which has become... ► Artikel lesen |
1 2 Weiter >>
34 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TEVA | 29,300 | +3,17 % | Teva Pharmaceutical Industries Ltd: Teva Expands European biosimilars portfolio with launch of AHZANTIVE (aflibercept) biosimilar to Eylea | AHZANTIVE (aflibercept) is an EMA-approved biosimilar to Eylea (aflibercept) with demonstrated similarity in efficacy, safety and immunogenicity to the reference product The launch expands Teva's biosimilars... ► Artikel lesen | |
| QUANTUM BIOPHARMA | 3,650 | -12,85 % | Quantum BioPharma Provides Corporate Update | THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. TORONTO, June 01, 2026... ► Artikel lesen | |
| TONIX PHARMACEUTICALS | 10,400 | +5,76 % | Tonix Pharmaceuticals legt Daten zur Opioid-Nutzung bei Fibromyalgie vor | ||
| MEDPACE | 396,40 | +2,01 % | XETR NEW INSTRUMENTS AVAILABLE ON XETRA - 04.06.2026 | Folgende Wertpapiere werden in den Handel an folgenden Handelsplätzen (MIC Code) im Quotation Board an der Frankfurter Wertpapierbörse (FWB) aufgenommen. Die Notierung an anderen Handelsplätzen im Quotation... ► Artikel lesen | |
| ALTIMMUNE | 2,500 | +1,21 % | Citizens reiterates Altimmune stock rating on fibrosis trial data | ||
| LIGAND PHARMACEUTICALS | 208,00 | +2,97 % | Orchestra BioMed Holdings, Inc.: Orchestra BioMed Receives $15 Million Investment from Ligand Under Previously Announced Strategic Financing Agreement | $15 million payment fulfills previously scheduled tranche under royalty-based financing agreement, bringing total capital received from Ligand to $40 million to date in exchange for tiered royalty... ► Artikel lesen | |
| JAGUAR HEALTH | 3,020 | -6,21 % | Jaguar Health, Inc.: Jaguar Health Research in Ethnobotanical Medicine Helps Advance Crofelemer Development for Genetically Defined Rare Congenital Gastrointestinal Disorders | Crofelemer delayed-release tablets are Jaguar's FDA-approved prescription drug under botanical guidance ("botanical drug") derived from the Croton lechleri tree. Crofelemer, in a novel liquid formulation... ► Artikel lesen | |
| XORTX THERAPEUTICS | 1,862 | +1,86 % | XORTX Therapeutics Inc.: XORTX Meets Nasdaq Continued Listing Requirements | CALGARY, Alberta, April 21, 2026 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the "Company") (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical pharmaceutical company focused... ► Artikel lesen | |
| ANI PHARMACEUTICALS | 67,50 | +3,85 % | ANI Pharmaceuticals, Inc.: ANI Pharmaceuticals Reports First Quarter 2026 Financial Results and Raises 2026 Financial Guidance | Quarterly net revenues of $237.5 million, an increase of 20.5% year-over-yearPurified Cortrophin- Gel net revenues of $75.1 million, an increase of 42.1% year-over-yearQuarterly GAAP net income available... ► Artikel lesen | |
| SOLIGENIX | 0,488 | +1,04 % | SOLIGENIX, INC. - 8-K, Current Report | ||
| CNBX PHARMACEUTICALS | - | - | CNBX Pharmaceuticals Inc. - 10-Q, Quarterly Report | ||
| KALA BIO | 2,280 | +1,79 % | XFRA 27F: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILKALA BIO INC. O.N.... ► Artikel lesen | |
| THERIVA BIOLOGICS | 0,284 | +1,36 % | Theriva Biologics, Inc.: Theriva Biologics Reports First Quarter 2026 Operational Highlights and Financial Results | - Alignment with the FDA on the Phase 3 trial design of VCN-01 (zabilugene almadenorepvec) for treatment of metastatic pancreatic ductal adenocarcinoma (PDAC) -
- Additional data from VIRAGE Phase... ► Artikel lesen | |
| HEPION PHARMACEUTICALS | 0,073 | -11,10 % | Hepion Pharmaceuticals, Inc.: Hepion Pharmaceuticals In-Licenses ctRNA Biomarker Assay to Facilitate Early Diagnosis and Surveillance of Hepatocellular Carcinoma | Next-generation, non-invasive diagnostic platform has potential applications in solid tumor types beyond liver cancer Licensing deal reflects Hepion's strategic shift to advancing clinically proven... ► Artikel lesen | |
| GRACE THERAPEUTICS | 2,380 | -2,86 % | Weekly Buzz: Sanofi, Regeneron Pharmaceuticals Get FDA Nod; It's A No For AbbVie, Grace Therapeutics; Eli Lilly Acquires Kelonia | NEW BRUNSWICK (dpa-AFX) - This week's biotech landscape witnessed regulatory approvals across the U.S. and Europe, alongside FDA rejections, acquisitions, and positive data readouts spanning... ► Artikel lesen |
Das Unternehmen SHUTTLE PHARMACEUTICALS HOLDINGS INC kann der Branche Pharma zugeordnet werden. Der aktuelle Kurs liegt bei 0,496 Euro und damit -5,60 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SHUTTLE PHARMACEUTICALS HOLDINGS INC finden Sie auf Wallstreet Online.